These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 18343056)

  • 21. Study of adverse outcomes in women using testosterone therapy.
    van Staa TP; Sprafka JM
    Maturitas; 2009 Jan; 62(1):76-80. PubMed ID: 19108962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical review: Controversies regarding transdermal androgen therapy in postmenopausal women.
    Basaria S; Dobs AS
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4743-52. PubMed ID: 16984993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety of testosterone use in women.
    Shufelt CL; Braunstein GD
    Maturitas; 2009 May; 63(1):63-6. PubMed ID: 19250779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast cancer incidence in postmenopausal women using testosterone in addition to usual hormone therapy.
    Dimitrakakis C; Jones RA; Liu A; Bondy CA
    Menopause; 2004; 11(5):531-5. PubMed ID: 15356405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of estrogen plus testosterone supplementation on breast cancer.
    Ness RB; Albano JD; McTiernan A; Cauley JA
    Arch Intern Med; 2009 Jan; 169(1):41-6. PubMed ID: 19139322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postmenopausal hormone therapy and breast cancer: where do we stand?
    Nelson AL
    Int J Fertil Womens Med; 2003; 48(5):206-16. PubMed ID: 14626377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hormone replacement therapy in postmenopausal women: all the treatments are not the same].
    Ribot C; Trémollieres F
    Gynecol Obstet Fertil; 2007 May; 35(5):388-97. PubMed ID: 17392010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Million Women Study: a licence to kill other investigations?
    van der Mooren MJ; Kenemans P
    Eur J Obstet Gynecol Reprod Biol; 2004 Mar; 113(1):3-5. PubMed ID: 15036701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety of estrogen/androgen regimens.
    Simon JA
    J Reprod Med; 2001 Mar; 46(3 Suppl):281-90. PubMed ID: 11304876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hormone replacement therapy in postmenopausal women and breast cancer risk: impact of estrogens deprivation and timing hypothesis].
    Brettes JP; Mathelin C
    Gynecol Obstet Fertil; 2007 Nov; 35(11):1092-4. PubMed ID: 17996474
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of combined estrogen-androgen preparations in the postmenopause: evidence from clinical studies.
    Sherwin BB
    Int J Fertil Womens Med; 1998; 43(2):98-103. PubMed ID: 9609209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is there a place for postmenopausal hormone therapy use in women with lupus?
    Gompel A; Piette JC
    Panminerva Med; 2008 Sep; 50(3):247-54. PubMed ID: 18927529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood pressure in middle-aged women: are androgens involved? A population-based study of Swedish women: the Women's Health in the Lund Area study.
    Khatibi A; Agardh CD; Nyberg P; Lidfeldt J; Samsioe G
    J Hypertens; 2007 Oct; 25(10):2044-50. PubMed ID: 17885546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postmenopausal hormone therapy and breast cancer.
    Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Menstrual and reproductive history, postmenopausal hormone use, and risk of benign proliferative epithelial disorders of the breast: a cohort study.
    Cui Y; Page DL; Lane DS; Rohan TE
    Breast Cancer Res Treat; 2009 Mar; 114(1):113-20. PubMed ID: 18360772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Stramba-Badiale M
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety of testosterone treatment in postmenopausal women.
    Braunstein GD
    Fertil Steril; 2007 Jul; 88(1):1-17. PubMed ID: 17493618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associations between serum testosterone levels, cell proliferation and progesterone receptor content in normal and malignant breast tissue in postmenopausal women.
    Hofling M; Löfgren L; von Schoultz E; Carlström K; Söderqvist G
    Gynecol Endocrinol; 2008 Jul; 24(7):405-10. PubMed ID: 18645713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The assessment of bleeding patterns in postmenopausal women during continuous combined hormone replacement therapy: a review of methodology and recommendations for reporting of the data.
    Archer DF; Pickar JH
    Climacteric; 2002 Mar; 5(1):45-59. PubMed ID: 11974559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.